제49차 대한순환기학회 추계 학술대회 일정

* 일시 : 2005년 9월 29일(목)~30일(금)                     

* 장소 : 그랜드힐튼호텔(홍제동 소재)                        

■ 특강
9월 30일(금) [제 1 회의장] 11:20-12:00

The Integrated Management of Angina in Diabetics	좌장 : 조승연
Bernard J. Gersh/ Mayo Clinic

■ 심포지움
9월 29일(목) [제 1 회의장]
Coronary Artery Disease - Coronary Artery Disease in Women

08:30-10:00	좌장 : 박의현, 심원흠
1. Coronary artery disease in women: underdiagnosed and undertreated  신길자/이화의대 2. Optimal diagnosis of coronary artery disease in women 심완주/고려의대 3. Gender differences in outcome of acute coronary syndrome  정명호/전남의대 4. Treatment and the role of hormaonal replaement therapy  김치정/중앙의대

Basic Research - Current Cardiovascular Research

14:00-15:30	좌장 : 박정의, 조명찬
1. Risk stratification for sudden cardiac in hypertrophic cardiomyopathy: implications of molecular genetics  Bernard J. Gersh/ Mayo Clinic 2. Integrin signalling in heart failure R. Ross/ UCSD 3. Pump up the heart: calcium cycling defect and heart diseases Susumu Minamisawa/ Yokohama City University 4. In vivo tracking of systemically injected, iron-labeled BM MSC in AMI rat with MRI 홍범기/연세의대

Atherosclerosis & Lipid - Optimal Treatment of Dyslipidemia and CHD Prevention

16:00-18:00	좌장 : 이원로, 박영배
1. New opportunities for targeting multiple lipid pathways Farnier Michel/ Point Medical Clinic 2. Effects of HMG-reductase inhibitors on Endothelial Function Preston Mason/ Harvard Medical School 3. Atherogenic lipid profile in metabolic syndrome 조홍근/연세대 4. Vascular inflammation and PPARs 김효수/서울의대

■ [제 2 회의장]
Hypertension - Optimizing TOD Risk Reduction with Hypertensive Patients

08:30-10:00	좌장 : 이방헌, 김재형
1. Morning surge in blood pressure accerelates TOD 김동수/인제의대 2. Role of angiotensin sympathetic overactivity in the metabolic syndrome Stevo Julius/ Michigan University 3. Role of CCB in high risk hypertension Gareth Beevers/ University of Birmingham 4. Hypertensive patient with renal damage 양철우/가톨릭의대

■ 9월 29일(목) [제 7 회의장]
Congenital and Pediatric Disease (1)

08:30-08:50	좌장 : 김철호, 윤향석
Endothelial dysfunction in postoperative congenital heart disease and Kawasaki disease- is it real? 홍자현/가톨릭의대

Congenital and Pediatric Disease (2)

10:30-11:10	좌장 : 이상범, 마재숙
1. How much popular is the metabolic syndrome in children? 반지은/부산의대 2. How do we prevent late postoperative arrhythmia? 현명철/경북의대

Congenital and Pediatric Disease (3)

14:00-14:20	좌장 : 박인숙, 이주원
What is the definition of small systemic ventricle?  길홍량/충남의대

Congenital and Pediatric Disease (4)

16:00-16:40	좌장 : 김용진, 이상호
1. Current issues in pediatric cardiac surgery  Glen S Van Arsdell/ The Hospital for Sick Children 2. Is it really better than systemic-to-pulmonary shunt for RV-PA conduit in stage I norwood procedure of    HLHS?  김시호/동아의대

■ 9월 30일(금) [제 1 회의장]
Heart Failure - Optimal Treatment of Heart Failure

08:30-10:00	좌장 : 노영무, 오병희
1. Prognostic variables in heart failure: risk stratification  채성철/경북의대 2. Optimal use of beta-blockade in heart failure  Willem J. Remme/ Sticares CVRI 3. Optimal treatment of RAA blockade in heart failure  Jan Bertil Ostergren/ Karolinska University 4. Surgical treatment of intractable heart failure  장병철/연세의대

Arrhythmia - Topic of CHF

13:30-15:00	좌장 : 최윤식, 김성순
1. Arrhythmogenesis and antiarrhythmics in CHF  남기병/울산의대 2. Prevention of SCD: ICD  최인석/가천의대 3. Pacing therapy (CRT)  신동구/영남의대 4. Catheter ablation of ventricular tachyarrhythmias in patients with organic heart disease Hwang Chun/ Utah Valley Regional Medical Center

Cardiac Imaging - Plaque Imaging

15:30-17:00	좌장 : 임태환, 범희승
1. CT plaque imaging 서준범/울산의대 2. MR plaque imaging  최연현/성균관의대 3. Nuclear plaque imaging  손형선/가톨릭의대 4. Ultrasonographic plaque imaging 홍명기/울산의대

[제 2 회의장]
Echo - Vexing Issues in Valvular Heart Disease

08:30-10:00	좌장 : 정남식, 손대원
1. Functional and ischemic mitral regurgitation : new evaluation and treatment strategies 박승우/성균관의대 2. Evaluation tricuspid regurgitation and RV function and its impact on clinical outcome and therapeutic strategies 하종원/연세의대 3. Echocardiographic assessment of aortic regurgitation : a practical approach 정해억/가톨릭의대 4. Mitral valve prolapse in Korea 송재관/울산의대

[제 7 회의장]
심장외과-Debate-Advanced Techniques and Technologies: Surgery or Percutaneous Intervention?

08:30-10:00	좌장 : 이영탁, 김윤년
1. Percutaneous intervention of unprotected left main disease: technical feasibility and clinical outcomes  박승정/울산의대 2. Triple vessel disease an left main disease: surgery v.s. stent 김기봉/서울의대 3. Catheter-based ablation for atrial fibrillation 김영훈/고려의대 4. Current surgical treatment for atrial fibrillation  이재원/울산의대

Congenital and Pediatric Disease (5)

13:30-14:10	좌장 : 박영환, 손세정
1. Hybrid procedures in pediatric cardiac surgery  Glen S Van Arsdell/ The Hospital for Sick Children 2. Surgical managements of TAPVC in functional single ventricle and postoperative pulmonary venous obstruction  윤태진/울산의대

■ Satellite Symposium
9월 28일(수) [18:00-19:30]
[제 1회의장]

1. Evolving CV Treatment Strategies: Insights from Recent Evidences	좌장 : 김종성, 이우형
1) The anglo-scandinavian cardiac outcomes trial(ASCOT) Gareth Beevers/ University of Birmingham 2) Multi-risk factor intervention strategy - combined effects of amlodipine and atorvastatin on endothelial dysfunction Preston Mason/ Harvard Medical School
[제 2회의장]
2. Cardio Update	좌장 : 이    영, 오동주
1) Cardiovascular protection with irbesartan - current data and future trials Peter E. Carson/ Veterans Affairs Medical Center 2) COMMIT and CLARITY implications for the practicing cardiologist John William Andrew Eikelboom/ McMaster University

9월 29일(목) [12:30-14:00]
[제 1회의장]

3. A New Analysis of VALUE Study Result : Outcomes in 7080 Patients Treated    with Monotherapy	좌장 : 김현승, 김철호
A new analysis of VALUE study result : outcomes in 7080 patients treated with monotherapy Stevo Julius/ University of Michigan
[제 2회의장]
4.The Maneuver to Reduce Cardiovascular Risk	좌장 : 노영무, 최경훈
1) Manifested advantage of targeting two pathways in cholesterol management Farnier Michell/Point Medical Clinic 2) Epidemiologic assessment for stroke prevention; hypertension and AF 박창규/고려의대
[제 3회의장]
5. The Role of CCB on Diastolic Function and Left Ventricular Hypertrophy     in Essential Hypertension	좌장 : 최규보, 이재우
1) Diastolic function and left ventricular hypertrophy in essential hypertension patients Kenji Sunagawa/ Kyushu University 2) Effect of cilnidipine vs atenolol on diastolic function and left ventricular hypertrophy in essential hypertension patients (CANDLE) - an interim report 정욱진/가천의대
[제 4회의장]
6. Carvedilol(Dilatrend) - 심부전 치료에 대한 최신 지견	좌장 : 배종화, 전재은
1) Beta-adrenergic system in heart failure  최동주/서울의대 2) Beta-blockade for the treatment of heart failure : further evidence emerging from COMET  Willem J. Remme/ Sticares CVRI
[제 5회의장]
7. Angiotensin Receptor Blockers in Hypertension and Heart Failure	좌장 : 이명묵, 유규형
1) Current aspects on angiotensin receptor blockade in hypertension Peter Andrew Meredith/ University of Glasgow 2) Evidence base for angiotensin receptor blockade in chronic heart failure Jan Bertil Ostergren/ Karolinska University

9월 29일(목) [18:00-19:00]
[제 1회의장]

8. Secondary Prevention of Coronary Artery Disease:    The Established Role of Perindopril	좌장 : 최윤식, 권영주
1) Prevention of events in coronary artery disease patients by inhibiting RAS system: the latest insights 김용진/서울의대 2) Inhibition of intimal/medial hyperplasia by perindopril in canine vein grafts Toshiya Nishibe/ Fujita University 3) From acute myocardial infarction to secondary prevention: evidence for benefits of perindopril in coronary artery disease patients Henry Purcell/ Royal Brompton Hospital
[제 2회의장]
9. Prevention Strategies by Blocking the Renin Angiotensin System     - Current Status and Future Challenges	좌장 : 신영우, 박의현
1) Prevention of cardiovascular events in high risk patients: working upstream to reduce the downstream burden of disease Norman Sharpe/ University of Auckland 2) Role of angiotensin receptor blocker in cardiovascular diseases 하종원/연세의대